Yexi Chen
Overview
Explore the profile of Yexi Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
370
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xiong X, Liu J, Wu X, Yao Z, Meng Y, Liu S, et al.
Sci Rep
. 2025 Feb;
15(1):7065.
PMID: 40016288
Lung metastasis is the primary cause of breast cancer-related mortality. Protein tyrosine phosphatases such as PTPRO are important in cancer progression. However, the role and underlying mechanisms of PTPRO in...
2.
Chen H, Yang Q, Zheng H, Tan J, Xie J, Xu M, et al.
Nutr J
. 2025 Feb;
24(1):28.
PMID: 39987440
Background: Cancer-related deaths and environmental issues pose significant global challenges. The Planetary Health Diet (PHD) is a healthy dietary pattern that simultaneously promotes human health and ecology. This study aims...
3.
Wang L, Lin Y, Yao Z, Babu N, Lin W, Chen C, et al.
Drug Resist Updat
. 2024 Aug;
76:101118.
PMID: 39094301
Aims: Resistance to targeted therapy is one of the critical obstacles in cancer management. Resistance to trastuzumab frequently develops in the treatment for HER2 cancers. The role of protein tyrosine...
4.
Li Q, Chen Y, Chen Y, Hua Z, Gong B, Liu Z, et al.
Biomed Pharmacother
. 2024 Apr;
174:116562.
PMID: 38626518
Rhabdomyosarcoma (RMS), a mesenchymal tumor occurring in the soft tissue of children, is associated with a defect in differentiation. This study unveils a novel anti-tumor mechanism of dimethylaminomicheliolide (DMAMCL), which...
5.
Zou J, Chen Y, Ji Z, Liu D, Chen X, Chen M, et al.
Transl Cancer Res
. 2024 Feb;
13(1):25-45.
PMID: 38410217
Background: is a gene that encodes the C4BP protein α chain and is involved in the complement system. is regarded as a new biomarker for cancer, especially for non-small cell...
6.
Liu Y, Wu J, Chen L, Zou J, Yang Q, Tian H, et al.
Heliyon
. 2024 Feb;
10(3):e24855.
PMID: 38318018
Breast cancer is the most frequent form of cancer in women and the primary cause of cancer-related deaths globally. DNA methylation and demethylation are important processes in human tumorigenesis. Ten-eleven...
7.
Wen Z, Zheng D, Wu J, Tian H, Yang Q, Chen L, et al.
Environ Sci Pollut Res Int
. 2024 Jan;
31(6):9251-9271.
PMID: 38191730
Lead poisoning in children is a non-negligible and ongoing threat to children's health and optimal development worldwide. There is no sufficient scientometric analysis available on this subject, though. Aiming to...
8.
Wu J, Zheng D, Wang H, Zhou Z, Yang Q, Wu J, et al.
Front Oncol
. 2023 Oct;
13:1273555.
PMID: 37854676
Introduction: Breast cancer remains a significant global health challenge, accounting for 2.3 million new cases in 2020 and ranking as the most prevalent cancer by incidence and the fourth in...
9.
Liu Y, Wu J, Ji Z, Chen L, Zou J, Zheng J, et al.
BMC Cancer
. 2023 Aug;
23(1):816.
PMID: 37653504
Background: This network meta-analysis aimed to assess the comparative efficacy and safety of combinations involving three cyclin-dependent kinase 4/6 (CDK4/6) inhibitors and endocrine therapies (ETs) in patients with metastatic or...
10.
Zhang X, Wu J, Yang Q, Tian H, Chen L, Zheng D, et al.
Front Oncol
. 2023 Aug;
13:1167154.
PMID: 37637052
Over the past decade, thousands of articles have been published on the mechanistic target of rapamycin (mTOR) and its role in breast cancer. However, the variability and heterogeneity of academic...